Results 301 to 310 of about 146,077 (348)

Application of humanized mice to toxicology studies: properties of chimeric mice with humanized liver (PXB-mice) for hepatotoxicity. [PDF]

J Toxicol Pathol
Sultana N, Izawa T, Kamei T, Fujiwara S, Ito Y, Takami Y, Kuwamura M.   +6 more
europepmc   +1 more source

Publisher Correction: Mitigating doxorubicin-induced hepatotoxicity in male rats: The role of aerobic interval training and curcumin supplementation in reducing oxidative stress, endoplasmic reticulum stress and apoptosis. [PDF]

Sci Rep
Zobeydi AM, Namavar SNM, Shahdani MS, Choobineh S, Kordi MR, Rakhshan K.   +5 more
europepmc   +1 more source

Liver transplantation, 1980, with particular reference to cyclosporin-A. [PDF]

, 1981
Iwatsuki, S, Klintmalm, G, Koep, LJ, Porter, KA, Schröter, GP, Starzl, TE, Weil, R   +6 more
core  

Natural History of Idiosyncratic Drug-Induced Liver Injury and Prognostic Models. [PDF]

Liver Int
Devarbhavi HC, Andrade RJ.
europepmc   +1 more source

Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis. [PDF]

BMC Genom Data
Mahajan R, Tyagi AK.
europepmc   +1 more source

Mechanistic and Molecular Insights into Empagliflozin's Role in Ferroptosis and Inflammation Trajectories in Acetaminophen-Induced Hepatotoxicity. [PDF]

Pharmaceuticals (Basel)
Alhaddad A, Mosalam EM, AboShabaan HS, Sallam AS, Mahfouz MM, Elhosary E, Mohammed AA, Metwally EM, Shaldam MA, Ghoneim ME.   +9 more
europepmc   +1 more source

Hepatotoxicity of Alogliptin [PDF]

Clinical Pharmacokinetics, 2014
In a recent article, Scheen [1] reviews the hepatic safety of incretin-based medications. The author concluded that ‘‘no hepatotoxicity has been reported in the development programme of alogliptin,’’ citing a review article from 2010, the year of alogliptin’s first approval (in Japan) [2].
Elizabeth Barbehenn, Sammy Almashat, Sidney Wolfe, Michael Carome   +3 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Hepatotoxicity of chemotherapy

Expert Opinion on Drug Safety, 2002
The selection of a chemotherapeutic regimen for the oncology patient is based on a thorough assessment of potential hazards relating to the patient's clinical condition and the toxicities of chemotherapy. Liver function abnormalities are commonly seen in this patient population and deducing their aetiology may be difficult.
Nasir Shahab, Bradley A. Sachs, Michael C. Perry, Syed Haider, Rama Balaraman   +4 more
openaire   +2 more sources